Heron Therapeutics, Inc. (NASDAQ:HRTX): Analyst Views in Focus - Bay City Observer

Heron Therapeutics, Inc. (NASDAQ:HRTX): Analyst Views in Focus  Bay City ObserverShares of Heron Therapeutics, Inc. (NASDAQ:HRTX) currently have an average target price of $52.9. This is the consensus number using estimates provided by.